Danish Aerospace Company (DAC) Investor update summary
Event summary combining transcript, slides, and related documents.
Investor update summary
28 Sep, 2026Company background and expertise
Over 34 years of experience delivering training and medical monitoring equipment for space since 1992.
Recognized as a leading supplier to NASA and ESA for astronaut exercise and health monitoring devices.
Holds AS9100 certification for both design and production.
Expanded into defense sector in 2021, developing equipment for extreme environments on Earth.
SME with approximately 24 employees, having delivered over 3.5 tons of space equipment in 35 years.
Product innovation and deployment
Developed CEVIS, a robust cycle ergometer used on space shuttles, Mir, and ISS for over 20 years.
Introduced FERGO (Teal CEVIS), a smaller, higher-load successor to CEVIS, adopted by NASA for ISS since October 2024.
E4D device combines cycling, rowing, weightlifting, and rope exercises in one compact unit, under testing for commercial space stations and lunar bases.
E4D features modular design for easy repair, supports multiple exercise modes, and offers full-body training flexibility.
Integration with Zwift virtual world enhances user engagement and training data collection.
Medical monitoring and wearable technology
Developed a wearable chest sensor delivering clinical-grade data for health monitoring in extreme conditions.
Sensor integrates ECG, heart rate, respiratory, IMU, and temperature monitoring, with advanced data analytics via ADAM software.
ADAM software enables secure, real-time data analysis and is used by ESA and NASA control centers.
Wearable technology tested on ISS and designed for both space and terrestrial professional applications.
Latest events from Danish Aerospace Company
- Net loss widened to DKK 2.3 million as revenue fell, but equity was boosted by a major rights issue.DAC
H1 2026 - 2025 saw higher revenue but lower EBITDA, with a major capital raise in 2026 boosting financial strength.DAC
H2 2025 - DKK 24.7 million rights issue in April 2026 funds growth, debt reduction, and dual-use expansion.DAC
Investor update - Net loss narrowed and revenue grew modestly, with key restructuring and development ongoing.DAC
H1 2025 - Net loss widened and revenue declined, but operating cash flow turned positive in H1 2024.DAC
H1 2024 - 2024 saw a net loss and missed targets, but 2025 guidance expects revenue and EBITDA recovery.DAC
H2 2024